Autonomic manipulation influences both temporal and frequency analyses of late potentials

• Published in: Pacing and clinical electrophysiology Vol. 15; no. 11 Pt 2; p. 2200
• Main Authors: Schwartzman, D, Demopoulos, L, Schrem, S, Caracciolo, E, Perez, J, Chinitz, L, Slater, W
• Format: Journal Article
• Language: English
• Published: United States 01.11.1992
• Subjects: Adrenergic beta-Antagonists; Atropine; Electrocardiography - methods; Female; Heart Conduction System - drug effects; Heart Conduction System - physiopathology; Humans; Isoproterenol; Male; Middle Aged; Myocardial Infarction - diagnosis; Myocardial Infarction - physiopathology; Propanolamines; Signal Processing, Computer-Assisted
• ISSN: 0147-8389
• DOI: 10.1111/j.1540-8159.1992.tb03047.x

Previous studies of late potentials have not standardized the autonomic milieu at the time of testing. We studied the effects of autonomic manipulation in seven patients with previous Q wave myocardial infarction. Late potentials were evaluated using standard temporal (TD) and spectral temporal mapping techniques (STM) in the drug free state, and during separate intravenous administration of each of the following: isoproterenol, esmolol, and atropine. Isoproterenol was titrated to achieve a heart rate of 130% of baseline. Esmolol was infused at a rate of 250 micrograms/kg per minute, after a loading dose of 500 micrograms/kg. Atropine was given as a 2-mg bolus. In addition, five patients who received no drug infusions acted as controls, undergoing four serial signal-averaging studies in the baseline state: a "baseline" study, and then three additional studies at time intervals similar to those incurred by the study patients. Therefore, a total of 21 TD and 21 STM tests were done in the study group (seven patients; three drugs per patient) during the drug infusions, and 15 TD and 15 STM tests were done in the control group (five patients; three "nonbaseline" tests per patient). A change (normal to abnormal, or vice versa) in TD during a drug infusion occurred in 24% of the tests. No such change occurred in the control group (P < 0.01). A change in STM during a drug infusion occurred in 38% of tests, versus 13% of tests in the control group (P = 0.14). Overall, six of seven patients had a change in TD and/or STM diagnosis with infusion of one or more of the study drugs.